Key points are not available for this paper at this time.
Abstract In the twenty-first century, the most valuable firms in the world are valued primarily for their data. This article describes a set of tools to measure and value data and highlights unanswered questions, where more research is needed.
Laura Veldkamp (Fri,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: